The second annual Trojan Heroes Among Us Jog-a-thon to fight cancer will take place Friday evening. The event will be held at the Jenks High School track from 6:00 to 8:00 p.m. and will serve as a fundraiser for cancer research at the Oklahoma Medical Research Foundation. The jog-a-thon is the brainchild of two Jenks […]
News
Kim Henry, four others to join OMRF board
At its semiannual board meeting this evening, the Oklahoma Medical Research Foundation will add Oklahoma First Lady Kim Henry and four others to its board of directors. Joining Henry as new board members will be Gary Pierson, Dave Lopez and Jerome Holmes of Oklahoma City and Gregory Walton, M.D., of Enid. Also this evening, OMRF […]
Eli Lilly and Company endows two chairs at the Oklahoma Medical Research Foundation with $6 million gift
Research at the Oklahoma Medical Research Foundation (OMRF) will receive a major boost with a $6 million gift from Eli Lilly and Company. OMRF will use the gift from the Indianapolis-based pharmaceutical company to create a pair of endowed faculty chairs – the Eli Lilly Chairs in Biomedical Research. For more than two decades, Lilly […]
Youth Wins Out During OMRF’s Junior Science Days
The laboratories at the Oklahoma Medical Research Foundation are typically pretty quiet places. But today and tomorrow, they will echo with the oohs and ahs of 35 youngsters who will don lab coats, goggles and gloves for the 25th installment of OMRF’s Junior Science Days. Thirty-five elementary, middle and high school students from the Putnam […]
OMRF Names Blair New VP for Institutional Advancement
The Oklahoma Medical Research Foundation announced today that it has named Steve Blair vice president for institutional advancement. Blair comes to OMRF with over a decade of development experience. Most recently, he served as external relations director for the Cardiovascular Center at the University of California, San Diego, where he raised more than $30 million […]
Zapaq completes $6 million financing
Zapaq, Inc., a drug discovery and development company, announced that it has obtained $6 million in private financing from two premier venture capital firms – Sanderling Ventures and Yamanouchi Venture Capital. “This financing allows us to make significant advances toward the clinical development of a compound that could delay or even halt the progression of […]
